These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18083719)

  • 1. Use of faecal excretion function for quick estimation of initial and existing lung burden for occupational exposure control due to 239Pu for S-class of intake.
    Yadav JR; Rao DD; Hegde AG; Aggarwal SK
    Radiat Prot Dosimetry; 2008; 129(4):403-10. PubMed ID: 18083719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and validation of a urinary excretion function for plutonium based on occupational exposure.
    Yadav JR; Rao DD; Hegde AG; Aggarwal SK
    Radiat Prot Dosimetry; 2008; 129(4):386-90. PubMed ID: 17974581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four years of follow-up for a Hanford plutonium wound case.
    Carbaugh EH; Lynch TP; Antonio CL; Medina-Del Valle F
    Health Phys; 2010 Oct; 99(4):483-94. PubMed ID: 20838089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and biological effects of inhaled 239Pu(NO3)4 in cynomolgus monkeys.
    Brooks AL; Guilmette RA; Hahn FF; Haley PJ; Muggenburg BA; Mewhinney JA; McClellan RO
    Radiat Res; 1992 Apr; 130(1):79-87. PubMed ID: 1561321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual monitoring for internal contamination with plutonium compounds at JAEA-NCL.
    Kurihara O; Kanai K
    Radiat Prot Dosimetry; 2011 Jul; 146(1-3):144-7. PubMed ID: 21493601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative role of plutonium excretion with urine and feces from human body.
    Khokhryakov VF; Suslova KG; Kudryavtseva TI; Schadilov AE; Vostrotin VV; Lagounova NY; Barabanshchikova AY
    Health Phys; 2004 May; 86(5):523-7. PubMed ID: 15083148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computational study of the urinary excretion rates for 339Pu using new ICRP internal dosimetry models.
    Singh IS; Sharma RC; Abani MC
    Radiat Prot Dosimetry; 2003; 105(1-4):361-4. PubMed ID: 14526987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of air monitoring and experimental aerosol data for intake assessment for Mayak plutonium workers.
    Zaytseva YV; Tretyakov FD; Romanov SA; Miller G; Bertelli L; Guilmette RA
    Radiat Prot Dosimetry; 2007; 127(1-4):535-9. PubMed ID: 17848389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifying effects of health status, physiological, and dosimetric factors on extrapulmonary organ distribution and excretion of inhaled plutonium in workers at the Mayak Production Association.
    Suslova KG; Khokhryakov VF; Tokarskaya ZB; Nifatov AP; Sokolova AB; Miller SC; Krahenbuhl MP
    Health Phys; 2006 Apr; 90(4):299-311. PubMed ID: 16538136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-year follow-up of a Pu/Am inhalation case.
    Wernli C; Eikenberg J
    Radiat Prot Dosimetry; 2007; 125(1-4):506-12. PubMed ID: 17298952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early faecal excretion of inhaled plutonium.
    Kurihara O; Momose T; Tasaki T; Hayashi N; Shinohara K
    Radiat Prot Dosimetry; 2002; 102(2):137-44. PubMed ID: 12408490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anomalously high excretion of Pu in urine following inhalation of plutonium nitrate?
    Etherington G; Stradling GN; Hodgson A; Fifield LK
    Radiat Prot Dosimetry; 2003; 105(1-4):321-4. PubMed ID: 14526978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncertainties in internal doses calculated for Mayak workers--a study of 63 cases.
    Miller G; Guilmette R; Bertelli L; Waters T; Romanov SA; Zaytseva YV
    Radiat Prot Dosimetry; 2008; 131(3):316-30. PubMed ID: 18689802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USTUR whole body case 0262: 33-y follow-up of PuO2 in a skin wound and associated axillary node.
    James AC; Sasser LB; Stuit DB; Wood TG; Glover SE; Lynch TP; Dagle GE
    Radiat Prot Dosimetry; 2007; 127(1-4):114-9. PubMed ID: 18227076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocation of plutonium from rat and monkey lung after inhalation of industrial plutonium oxide and mixed uranium and plutonium oxide.
    Lataillade G; Verry M; Rateau G; Métivier H; Masse R
    Int J Radiat Biol; 1995 Mar; 67(3):373-80. PubMed ID: 7897285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention of 239Pu in the mouse lung and estimation of consequent dose following inhalation of sized 239PuO2.
    Morgan A; Black A; Moores SR; Lambert BE
    Radiat Res; 1984 Aug; 99(2):272-84. PubMed ID: 6463206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The applicability of the concept of morpho-physiologic metabolic factors to the modification of the distribution of 239Pu deposited in the respiratory organs].
    Shvydko NS; Ivanova NP; Rushonik SI
    Radiobiologiia; 1990; 30(5):665-70. PubMed ID: 2251355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of multi-compartment wound models to plutonium-contaminated wounds incurred by former workers at rocky flats.
    Falk RB; Daugherty NM; Aldrich JM; Furman FJ; Hilmas DE
    Health Phys; 2006 Aug; 91(2):128-43. PubMed ID: 16832194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.